menu close
www.biocatch.com

BioCatch Stock

Company Profile:

BioCatch, Inc. is a United States company, which provides behavioral authentication and threat detection. The Company provides solutions for mobile and Web applications. Available as a cloud-based solution, the Company collects and analyzes more than 400 bio-behavioral, cognitive and physiological parameters to generate a user profile. Its technology helps banking and eCommerce users against cyber threats, such as Account Takeovers, Man-in-the-Browser (MitB) Malware and Remote Access (RAT) attacks. The Company creates a behavioral biometric signature that it associates with the user profile. If deviations are detected, then a real-time alert can be sent to the bank or e-commerce site. BioCatch monitors how users interact with online and mobile applications.

Sign up for SecondMarket™ to view the market and buy or sell BioCatch Stock
Buy + Sell
Leverage Your Equity to Help Achieve More.

BioCatch Management Team

  • Founder

    Uri Rivner

  • Chief Revenue Officer

    Mike Keating

  • Director

    Dominik Pozny

  • Director

    Sallie Krawcheck

  • Director

    Liat Nadai Arad

  • Director

    Ran Maidan

  • Founder

    Avi Turgeman

  • COO

    Eyran Blumberg

  • Founder

    Benny Rosenbaum

  • Director

    Stefan Dziarski

  • CEO, Director

    Gadi Mazor

BioCatch Major Investors

  • Blumberg International Partners LLC

Learn More About BioCatch Stock

Buy BioCatch Stock
01

BioCatch stock does not trade on public stock exchanges. BioCatch stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BioCatch stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell BioCatch Stock
02

BioCatch Stock does not trade on public stock exchanges. In order to sell BioCatch shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

BioCatch Stock Price
03

BioCatch does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view BioCatch share price and other valuable private market data.

Read more about secondary market private company stock prices:

BioCatch Stock Ticker Symbol
04

There is no ticker symbol for BioCatch stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell BioCatch Stock
05

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BioCatch stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in BioCatch Stock
06

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BioCatch stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

BioCatch Stock Settlement
07

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

BioCatch IPO
08

BioCatch is a private company and has not had an IPO. There is currently no BioCatch IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to BioCatch IPO.

Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.

Sign up for SecondMarket™ to view the market and buy or sell BioCatch Stock
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Grammarly-Logo

Grammarly

AI-powered writing assistant.

Databricks-Logo

Databricks

Open analytics platform providing enterprise-grade data, analytics, and AI solutions at scale.

Scaleai-Logo

Scale AI

Generative AI platform leveraging enterprise data and foundation models for businesses.

Canva-Logo

Canva

Online design and publishing tool.

Xai - Logo

xAI

Artificial intelligence for human scientific discovery.

Alchemyinc-Logo

Alchemy Insights

Develops scalable and reliable decentralized applications without the hassle of managing blockchain infrastructure in-house.

Clickup App-Logo

ClickUp

Customizable productivity platform.

Motive Inc-Logo

Motive

Technology company that builds products to improve the safety, productivity, and profitability of businesses that power the physical economy.

Yuga Labs-Logo

Yuga Labs

Web3 company focused on reinventing real-world utility for NFTs.

Source: Nasdaq Private Market Tape D™